Cannabis has been used to treat a bevy of medical ailments since its first listing in the third edition of the United States Pharmacopeia in the 1800s.  Prior to its racially charged prohibition and criminalization, cannabis was used to treat epilepsy, opioid addiction, and pain by medical practitioners across the country.  Today cannabis is used to treat and reduce symptomatology for a  variety of neuropsychiatric ailments including PTSD, anxiety, migraines, and seizures.  This presentation will review the current literature on these conditions with a focus on the pathophysiology of the disease, the role of the endocannabinoid system in the disease state, and the pharmacological implications of cannabis-based medicine for the treatment of the ailment.

Cannabis as a treatment for neuropsychiatric conditions: A review

ACS Spring Meeting 2021

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.